APA (7th ed.) Citation

WW, C., SC, L., Q, Y., ML, X., JJ, Z., XR, Z., . . . LY, Z. (2026). Dynamic circulating biomarkers for predicting adverse events in PRaG therapy: A pooled analysis and model construction from PRaG series clinical trials. Cancer immunology, immunotherapy : CII, 75(2), 49. https://doi.org/10.1007/s00262-025-04292-w

Chicago Style (17th ed.) Citation

WW, Chen, Li SC, Yin Q, Xu ML, Zhang JJ, Zhao XR, Xing PF, Kong YH, and Zhang LY. "Dynamic Circulating Biomarkers for Predicting Adverse Events in PRaG Therapy: A Pooled Analysis and Model Construction from PRaG Series Clinical Trials." Cancer Immunology, Immunotherapy : CII 75, no. 2 (2026): 49. https://doi.org/10.1007/s00262-025-04292-w.

MLA (9th ed.) Citation

WW, Chen, et al. "Dynamic Circulating Biomarkers for Predicting Adverse Events in PRaG Therapy: A Pooled Analysis and Model Construction from PRaG Series Clinical Trials." Cancer Immunology, Immunotherapy : CII, vol. 75, no. 2, 2026, p. 49, https://doi.org/10.1007/s00262-025-04292-w.